Tocilizumab in COVID-19 management: addressing time of starting treatment
Open Access
- 6 January 2022
- journal article
- letter
- Published by BMJ in European Journal of Hospital Pharmacy
- Vol. 30 (2) , e9
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19JAMA Internal Medicine, 2021
- Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19European Journal of Hospital Pharmacy, 2021
- Genetic mechanisms of critical illness in COVID-19Nature, 2020
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory FailureCell Host & Microbe, 2020